This page is part of the FHIR Specification (v4.0.1: R4 - Mixed Normative and STU ) in it's permanent home (it will always be available at this URL). The current version which supercedes this version is 5.0.0 . For a full list of available versions, see the Directory of published versions . Page versions: R4 R3 R2
4.3.15.252 HL7 Version 2 Table 0252
This is a table defined as part of HL7 v2 .
Summary
Code System URL: http://terminology.hl7.org/CodeSystem/v2-0252
Value Set URL: http://terminology.hl7.org/ValueSet/v2-0252
Version: 2.9
Name: v2.0252
Title: v2 Causality Observations
Definition: FHIR Value set/code system definition for HL7 v2 table 0252 ( Causality Observations)
OID: ??
CodeSystem Resource XML / JSON
ValueSet Resource XML / JSON
Note: V2 code systems may or may not be case sensitive. V2 Code systems will have the CodeSystem.caseSensitive
correctly populated in a future version of this specification.
This value set is not currently used
4.3.15.252.1 Code System Content
This code system http://terminology.hl7.org/CodeSystem/v2-0252 defines the following codes:
Code Display Definition Version AW en: Abatement of event after product withdrawn nl: Vermindering gebeurtenis na terugtrekken product added v2.3 BE en: Event recurred after product reintroduced nl: Gebeurtenis trad opnieuw op na herintroductie product added v2.3 DR en: Dose response observed nl: Dosis reactie geobserveerd added v2.3 EX en: Alternative explanations for the event available nl: Alternatieve verklaringen voor gebeurtenis beschikbaar added v2.3 IN en: Event occurred after product introduced nl: Gebeurtenis trad op na introductie product added v2.3 LI en: Literature reports association of product with event nl: Literatuur vermeldt koppeling van product met gebeurtenis added v2.3 OE en: Occurrence of event was confirmed by objective evidence nl: Optreden van gebeurtenis is bevestigd door objectief bewijs added v2.3 OT en: Other nl: Anders added v2.3 PL en: Effect observed when patient receives placebo nl: Effect geobserveerd wanneer patiënt placebo krijgt added v2.3 SE en: Similar events in past for this patient nl: Vergelijkbare gebeurtenissen in verleden voor deze patiënt added v2.3 TC en: Toxic levels of product documented in blood or body fluids nl: Toxische niveaus van product gedocumenteerd in bloed of lichaamssappen added v2.3
This code system http://terminology.hl7.org/CodeSystem/v2-0252 defines the following codes:
Code Display Definition Version AW Abatement of event after product withdrawn added v2.3 BE Event recurred after product reintroduced added v2.3 DR Dose response observed added v2.3 EX Alternative explanations for the event available added v2.3 IN Event occurred after product introduced added v2.3 LI Literature reports association of product with event added v2.3 OE Occurrence of event was confirmed by objective evidence added v2.3 OT Other added v2.3 PL Effect observed when patient receives placebo added v2.3 SE Similar events in past for this patient added v2.3 TC Toxic levels of product documented in blood or body fluids added v2.3
Dit code systeem http://terminology.hl7.org/CodeSystem/v2-0252 definieert de volgende codes:
Code Display Definition Versie AW Vermindering gebeurtenis na terugtrekken product added v2.3 BE Gebeurtenis trad opnieuw op na herintroductie product added v2.3 DR Dosis reactie geobserveerd added v2.3 EX Alternatieve verklaringen voor gebeurtenis beschikbaar added v2.3 IN Gebeurtenis trad op na introductie product added v2.3 LI Literatuur vermeldt koppeling van product met gebeurtenis added v2.3 OE Optreden van gebeurtenis is bevestigd door objectief bewijs added v2.3 OT Anders added v2.3 PL Effect geobserveerd wanneer patiënt placebo krijgt added v2.3 SE Vergelijkbare gebeurtenissen in verleden voor deze patiënt added v2.3 TC Toxische niveaus van product gedocumenteerd in bloed of lichaamssappen added v2.3